EMCDDA. New drugs in Europe, 2013, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 1 Jul 2014. 311 kB.
Jones, LE; Stewart, A; Peters, KL; McNaul, M; Speers, SJ; Fletcher, NC; Bell, SEJ. Infrared and Raman screening of seized novel psychoactive substances: a large scale study of >200 samples. Analyst, 25 Jan 2016, 141 (3), 902–909. 1.3 MB. https://doi.org/10.1039/c5an02326b
Majchrzak, M; Celiński, R. Cathinone derivatives and their analysis. In Chromatographic Techniques in the Forensic Analysis of Designer Drugs; Kowalska, T; Sajewicz, M; Sherma, J, Eds., CRC Press, Taylor & Francis Group, 1 Jan 2018; pp 251–276. 1.1 MB.
Sasaki, R; Kato, M; Matsumoto, T; Udagawa, A; Matsuzaki, R. A method for identifying designer drugs of synthetic cathinones. JCCL, 1 Dec 2015, (55), 17–41. 663 kB. #27 Japanese, English abstract MS,NMR,IR,UV
Uchiyama, N; Matsuda, S; Kawamura, M; Shimokawa, Y; Kikura-Hanajiri, R; Aritake, K; Urade, Y; Goda, Y. Characterization of four new designer drugs, 5-chloro-NNEI, NNEI indazole analog, α-PHPP and α-POP, with 11 newly distributed designer drugs in illegal products. Forensic Sci. Int., 1 Oct 2014, 243, 1–13. 742 kB. https://doi.org/10.1016/j.forsciint.2014.03.013 #6, PHPP GC,LC,MS,NMR,UV
Chen, Y; Canal, CE. Structure–activity relationship study of psychostimulant synthetic cathinones reveals nanomolar antagonist potency of α-pyrrolidinohexiophenone at human muscarinic M2 receptors. ACS Chem. Neurosci., 18 Mar 2020, 11 (6), 960–968. 1.2 MB. https://doi.org/10.1021/acschemneuro.0c00008 #α-PHPP